Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Parallel Advisors LLC
Parallel Advisors LLC lowered its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 12.8% in the first quarter, Holdings Channel.com reports. The fund owned 346 shares of the medical research company’s stock after selling 51 shares during the quarter. Parallel Advisors LLC’s holdings in Bio-Rad Laboratories were worth $84,000 at the […]
